Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans
Data up to Jan 2025
Total Citations Per Year
Abstract
References (53)
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 • 3,182 citations
Simplified Reference Tissue Model for PET Receptor Studies
1996 • 1,980 citations
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate
1983 • 1,400 citations
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain
1985 • 1,294 citations
Study of a New Schizophrenomimetic Drug—Sernyl
1959 • 922 citations
Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
1965 • 717 citations
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
1980 • 703 citations
Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics
1997 • 670 citations
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
1996 • 667 citations
ARCHIVES OF NEUROLOGY AND PSYCHIATRY
1923 • 584 citations
The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
1998 • 510 citations
Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies
1996 • 461 citations
NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine
1996 • 450 citations
Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.
1992 • 412 citations
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
1997 • 393 citations
Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia
1989 • 392 citations
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
1997 • 388 citations
Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo
1993 • 386 citations
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
1997 • 349 citations
SPECT imaging of striatal dopamine release after amphetamine challenge.
1995 • 330 citations
Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels
1993 • 285 citations
5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride
1999 • 277 citations
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
1989 • 250 citations
Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
1989 • 201 citations
Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects
1998 • 199 citations
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
1998 • 197 citations
Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain.
1993 • 183 citations
Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study
1988 • 175 citations
Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics
1997 • 171 citations
Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats
1982 • 171 citations
Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5-HT2 Receptor and α1-Adrenoreceptor Antagonism
1995 • 154 citations
Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
1996 • 125 citations
Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
1995 • 123 citations
MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists
1993 • 122 citations
Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
1996 • 117 citations
Increases in strychnine-insensiive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis
1994 • 114 citations
Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization
1993 • 111 citations
MK-801 elevates the etracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors
1993 • 92 citations
Alterations in phencyclidine and sigma binding sites in schizophrenic brains
1991 • 90 citations
Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study
1994 • 89 citations
NMDA receptor related agents : biochemistry, pharmacology and behavior
1991 • 86 citations
Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis
1996 • 77 citations
Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics
1991 • 71 citations
The role ofN-methyl-d-aspartate receptors in the regulation of physiologically released dopamine
1995 • 61 citations
Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia.
1995 • 58 citations
Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study
1998 • 58 citations
Inhibitory Effect of MK-801 on Amantadine-Induced Dopamine Release in the Rat Striatum
1996 • 50 citations
Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl) guanidine on non-dopaminergic midbrain neurons
1993 • 47 citations
The chiral forms of ketamine as probes for NMDA receptor functions in humans
1991 • 44 citations
Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system
1994 • 43 citations
The Study of Neurotransmitter Interactions Using Positron Emission Tomography and Functional Coupling
1996 • 19 citations
Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801
1997 • 17 citations
The N-methyl-D-aspartate receptor and schizophrenia.
1996 • 6 citations